Related Experiment Videos
Different rhinovirus serotypes neutralized by antipeptide antibodies
Nature
|October 22, 1987
Summary
Researchers developed site-specific antibodies targeting conserved sequences in human rhinovirus. These antibodies neutralize most tested rhinovirus serotypes, offering a potential pathway toward a broad-spectrum rhinovirus vaccine.
Area of Science:
- Virology
- Structural Biology
- Immunology
Background:
- Human rhinoviruses share conserved amino acid sequences critical for receptor binding site topology.
- Understanding rhinovirus structure is key to developing broad-spectrum antiviral strategies.
Purpose of the Study:
- To develop neutralizing antibodies against human rhinovirus using conserved sequence epitopes.
- To assess the potential of these antibodies for a broadly effective rhinovirus vaccine.
Main Methods:
- Determined the three-dimensional structure of human rhinovirus.
- Identified conserved amino acid sequences near the receptor binding site.
- Prepared site-specific antibodies against synthetic peptides of these sequences.
- Tested antibody neutralization of various rhinovirus serotypes.
Main Results:
- Site-specific antibodies were successfully generated against conserved rhinovirus sequences.
- These antibodies bind to predicted rhinovirus capsid proteins.
- Approximately 60% of 48 tested rhinovirus serotypes were neutralized.
Conclusions:
- Conserved sequences in rhinovirus are viable targets for neutralizing antibodies.
- Antibodies targeting these sequences show potential for a broad-spectrum rhinovirus vaccine.
- This approach could overcome the challenge of numerous rhinovirus serotypes.